Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Plunges 4%; BSE HEALTHCARE Index Down 0.9%
Mon, 4 Nov 9:31

INDRAPRASTHA MEDICAL Plunges 4%; BSE HEALTHCARE Index Down 0.9%Image source: Nikada/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has plunged 4% and is presently trading at Rs 393.3.

Meanwhile, the BSE HEALTHCARE index is at 43,839.4 (down 0.9%).

Among the top losers in the BSE HEALTHCARE index today are J.B.Chemicals (down 3.2%) and Sun Pharma (down 3.1%).

MAX HEALTHCARE INSTITUTE (up 2.7%) and KIMS (up 2.0%) are among the top gainers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 165.7 to Rs 393.3, registering a gain of Rs 227.6 (up 137.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,271.8 to 43,839.4, registering a gain of 60.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 234.8%), SUVEN PHARMACEUTICALS (up 126.5%) and Glenmark Pharma (up 125.0%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,053.5 (down 1.0%).

The top losers among the BSE Sensex today are Sun Pharma (down 3.1%) and Infosys (down 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,076.7 (down 0.9%). Bajaj Auto and IOC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,874.9 to 79,053.5, registering a gain of 15,178.5 points (up 23.8%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 29.1% YoY to Rs 424 million for the quarter ended September 2024, compared to a profit of Rs 329 million a year ago. Net sales rose 10.4% to Rs 3,498 million during the period as against Rs 3,170 million in July-September 2023.

For the year ended March 2024, INDRAPRASTHA MEDICAL reported 43.9% increase in net profit to Rs 1,240 million compared to net profit of Rs 862 million during FY23. Revenue of the company grew 13.3% to Rs 12,447 million during FY24.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 24.4.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Plunges 4%; BSE HEALTHCARE Index Down 0.9%". Click here!